Delek Group is an independent E&P and the pioneering visionary behind the development of the East Med. With major finds in the Levant Basin, including Leviathan (21.4 TCF) and Tamar (11.2 TCF) and others, Delek is leading the region’s development into a major natural gas export hub. In addition, Delek has embarked on an international expansion with a focus on high-potential opportunities in the North Sea and North America. Delek Group is one of Israel’s largest and most prominent companies with a consistent track record of growth. Its shares are traded on the Tel Aviv Stock Exchange (TASE:DLEKG) and are part of the TA 35 Index.
We're tracking Delek Group's market expansion
How Delek Group's international expansion compares to its competitors
Delek GroupYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Delek GroupYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Tel Aviv Stock Exchange fell sharply with banks leading losses. Tel Aviv 35 Index down 1.89%, turnover NIS 7.49 billion in equities.
Barclays raised target price for Delek Group, seeing 54% upside potential and 24% for NewMed Energy. Cites strong financials and Leviathan gas field expansion approval.
Tel Aviv Stock Exchange rose with Teva Pharmaceutical leading gains. Most indices and major stocks increased.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Delek Group's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
